EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1

Historical Holders from Q4 2014 to Q4 2017

Type / Class
Debt / NOTE 2.875% 1/1
All holders as of 31 Dec 2017
Q4 2017
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1

Period Principal Value Change Price Investors
2017 Q4 0 $0 -$308,628,161 0
2017 Q3 214,385,363 $308,628,161 +$44,874 $1.44 27
2017 Q2 219,175,859 $283,130,913 +$3,581,815 $1.29 24
2017 Q1 217,075,867 $259,382,431 -$17,823,169 $1.20 25
2016 Q4 229,679,898 $293,411,749 -$23,255,011 $1.28 27
2016 Q3 246,559,034 $305,508,159 +$9,514,792 $1.23 32
2016 Q2 221,501,890 $251,307,146 -$7,655,177 $1.13 34
2016 Q1 237,209,005 $308,020,766 -$817,183,360 $1.30 34
2015 Q4 236,667,779 $1,138,303,069 -$30,325,394 $1.38 30
2015 Q3 230,065,336 $260,805,850 +$39,921,026 $1.13 32
2015 Q2 183,906,988 $228,027,350 +$34,643,556 $1.24 25
2015 Q1 155,973,674 $181,055,775 +$170,695,648 $1.16 23
2014 Q4 8,894,000 $10,011,000 +$10,011,000 $1.13 1